A detailed history of Davidson Capital Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Davidson Capital Management Inc. holds 3,538 shares of LLY stock, worth $2.82 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
3,538
Previous 4,031 12.23%
Holding current value
$2.82 Million
Previous $3.65 Million 14.11%
% of portfolio
0.91%
Previous 1.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$772.14 - $960.02 $380,665 - $473,289
-493 Reduced 12.23%
3,538 $3.13 Million
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $571,922 - $717,232
789 Added 24.34%
4,031 $3.65 Million
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $1.92 Million - $2.57 Million
3,242 New
3,242 $2.52 Million
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $1,929 - $2,248
6 New
6 $2,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Davidson Capital Management Inc. Portfolio

Follow Davidson Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Davidson Capital Management Inc. with notifications on news.